The alternatively spliced domains EIIIB and EIIIA of human fibronectin affect cell adhesion and spreading by Hashimoto-Uoshima, M et al.
2271Journal of Cell Science 110, 2271-2280 (1997)
Printed in Great Britain © The Company of Biologists Limited 1997
JCS8155The alternatively spliced domains EIIIB and EIIIA of human fibronectin affect
cell adhesion and spreading
Mariko Hashimoto-Uoshima1,*, Ying Zhuo Yan1, Galen Schneider2 and Ikramuddin Aukhil1,†
1Department of Periodontics and Dental Research Center and 2Department of Prosthodontics and Dental Research Center,
University of North Carolina, Chapel Hill, NC 27599-7450, USA
*Present address: Tokyo Medical and Dental University, Tokyo, Japan
†Author for correspondence (e-mail: aukhil.drc@mhs.unc.edu)Fibronectin has a complex pattern of alternative splicing at
the pre-mRNA level leading to the expression of different
isoforms. The alternatively spliced domains EIIIB and
EIIIA are known to be prominently expressed during
development and wound healing. While the other spliced
domain (CS-segment) is known to promote cell adhesion in
a cell type specific manner, the biological functions of the
spliced domains EIIIB and EIIIA are not well understood.
In the present study, we have prepared expression proteins
of specific domains of human fibronectin using a prokary-
otic expression system and used the purified fragments to
test their ability to support adhesion and spreading of
cultured cells. Fragments from type-III domains #7 to #12
were prepared in various combinations to include or
exclude the spliced domains EIIIB and EIIIA. The results
indicate that cultured NIL fibroblasts adhere to many of
the fragments tested. However, the cell adhesion and
spreading are enhanced, especially at lower concentrations,
to fragments including the domain EIIIB. The inclusion of
domain EIIIA led to a decrease in the adhesion of cells and
those that adhered did not spread well. When tested in a
centrifugal cell adhesion assay, fragments including
domain EIIIB resisted the detaching forces and stayed
adhered. Fragments that included domain EIIIA were
unable to resist the detaching centrifugal forces to the same
extent as the fragments that included domain EIIIB alone.
These results suggest that the spliced domain EIIIB may be
serving important biological functions in enhancing cell
adhesion and spreading. This is likely to be mediated by
conformational effects because domain EIIIB alone neither
exhibited any adhesive activity nor competed in inhibiting
adhesion to fragments #7-10. 
Key words: Fibronectin, Domain EIIIB, Domain EIIIA, Cell
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SUMMARYINTRODUCTION
The biological role of the extracellular matrix glycoprotein
fibronectin (FN) in cell adhesion and migration, development,
and wound healing has been extensively studied (Hynes, 1990).
Fibronectins (FNs) are a group of related glycoproteins that
arise from alternative splicing of the single FN gene transcript.
FNs have a relatively simple structure and consist of a dimer
of two subunits joined by disulfide bonds near the COOH
termini (Hynes, 1990). Three types of homologous repeating
units (referred to as types I, II and III domains/repeats) form
each subunit. Alternative splicing of a single primary transcript
leads to the inclusion or exclusion of three domains in the
central part of the molecule. Among the various functions of
FN, cell adhesion is by far the most extensively studied. The
short polypeptide sequence Arg-Gly-Asp (RGD), located in the
10th type-III repeating unit of FN, has been identified as the
important binding site for several integrin cell surface
receptors. The other cell adhesion site identified within FN is
referred to as the III CS (connecting segment) and this domain
is also subject to alternative splicing at the pre-mRNA level
(Humphries et al., 1987, 1988). The biological function(s) ofthe two remaining alternatively spliced domains EIIIB and
EIIIA is/are not known. It has, however, been well documented
that the domains EIIIB and EIIIA of FN are prominently
expressed during embryonic development and this embryonic
pattern of mRNA expression reappears in healing wounds
(ffrench-Constant and Hynes, 1989; ffrench-Constant et al.,
1989). The expression of FN mRNA, including domains EIIIB
and EIIIA, in the early chick embryo coincides at stages where
there is active proliferation and migration of cells (ffrench-
Constant and Hynes, 1989). Findings from a more recent study
suggest that the alternatively spliced domains EIIIB and EIIIA
are included in FN required for morphogenesis of ‘FN
dependent’ structures during development (Peters and Hynes,
1996). Using immunohistochemistry, it has also been shown
recently that the spliced domain EIIIB is included in FN around
the walls of some smaller blood vessels and within cartilagi-
nous structures (Peters et al., 1996). The possibility exists that
these spliced domains of FN (EIIIB and EIIIA) may have
important biological functions in the regulation of critical
cellular events during embryonic development and wound
healing. 
Many of the biological functions of FNs have been mapped
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types of studies have several disadvantages including overlap-
ping functional sites and the lack of information on the isoform
in question. Potentially, there may be as many as 20 different
isoforms of FNs possible due to alternative splicing of the
primary transcript (Hynes, 1990). Hence, studies aimed at
mapping the biological functions of the spliced domains EIIIB
and EIIIA should focus on methods that will provide clean
fragments that begin and end precisely at individual domains.
In the present study, we have generated several types of recom-
binant polypeptide fragments of human FN by amplifying
cDNA coding for the type-III domains #7-12 and cloning them
into prokaryotic expression vectors. By including or excluding
the spliced domains EIIIB and EIIIA, we were able to obtain
ten different fragments in various combinations of the domains.
These expressed domains of human FN were then purified and
used to study cell adhesion. In this study, we demonstrate that
the inclusion of spliced domain EIIIB alone or in combination
with EIIIA, within the larger fragment of FNIII #7-12, has an
enhancing effect on the adhesion and spreading of NIL fibro-
blasts. However, the spliced domain EIIIA alone, within the
fragment FNIII #7-12, led to a reduction in the adhesion and
spreading of cells. Since the domain EIIIB did not reveal any
cell adhesion promoting activity when tested as a single-
domain fragment, it is concluded that the domain EIIIB may
be influencing cell adhesion by exerting conformational effects
on the molecule. 
MATERIALS AND METHODS 
Materials
Human plasma FN (pFN) was provided by Dr Harold Erickson, Duke
University, Durham NC. The monoclonal antibody 16G3, which has
its epitope in the 10th type-III domain of human FN, was provided by
Drs K. Yamada and S. Aota, NIDR, NIH. The mAB 7F9 to vinculin
was provided by Dr A. Belkin. The prokaryotic expression vectors
pET 11b and pET 15b were from Novagen, Inc, Madison, Wis., and
the pGEM vector was from Promega Corp. Oligonucleotide primers
were synthesized at the Pathology Department Oligonucleotide
Facility at the University of North Carolina Chapel Hill using an ABI-
Model 394 Machine. [35S]dATP was from Amersham Corp, Isopropyl
β-D-thiogalactosidase (IPTG) was from Gibco, and all other
enzymes/reagents were from New England Biolabs or Promega. 
Cloning specific domains of human FN into pET
expression vectors 
The methods used to produce and purify bacterial expression proteins
were essentially the same as described previously with some modifi-
cations (Aukhil et al., 1993). The prokaryotic expression vector pET
11b (Studier et al., 1990) and its modified version pET 15b with a
histidine tag to facilitate affinity chromatography were used. The
strategy we have used enables us to clone fragments that begin and end
precisely at the boundaries of individual domains of FN. Briefly,
oligonucleotide primers with the appropriate restriction sites were
designed to amplify fragments of human FN cDNA. The cDNA
template used was made by reverse transcription of total RNA
extracted from cultured human periodontal ligament fibroblasts. The
various recombinant human FN fragments that include or exclude the
alternatively spliced domains EIIIB and EIIIA are shown in Fig. 1.
Both the forward and reverse oligonucleotide primers for DNA ampli-
fication shown in Table 1 were synthesized (18-21 bases) correspond-
ing to the 5′ and 3′ terminal sequences of the desired coding segment.
The forward primer was designed to incorporate the NdeI site imme-diately before the first codon and included the ATG start codon in the
last three bases of its restriction sequence. The reverse primer included
a stop codon after the codon for the last amino acid in the fragment to
be amplified and was the followed by a BamHI site to facilitate direc-
tional cloning into pET vectors. Total RNA was isolated from cultured
human periodontal ligament fibroblasts in their 4th and 5th passages
and reverse transcribed using random hexamers (Kawasaki, 1990). The
reverse transcription product was used as a template to amplify
domains of human FN using Taq polymerase as described (Aukhil et
al., 1993). Amplification of cDNA was verified by running samples on
agarose gels and the amplified product was restriction digested with
the appropriate enzymes. The fragments were initially cloned into
pGEM-7 vector and their sequence verified by the dideoxynucleotide
method (Sanger et al., 1977). Subsequently, the cDNA fragments were
cloned into the NdeI and BamHI sites of the vector pET 11b or pET
15b. Fragments including FN Type-III domain #9 were subjected to
limited digestion with BamHI because of an intrinsic restriction site in
this domain. Initially, the fragments FN-III domains 7-10(−B),
7-10(+B), 10-12(−A) and 10-12(+A) were made and sequenced. The
larger fragments and their combinations were made by using restric-
tion digested segments. For example, the fragment Fn-III 7-12+B+A
was assembled by using the PvuII digested fragments of 7-10+B and
10-12+A. The fragment coding for domains 7-12−B−A was assembled
using the Eco-0109 site in domain #10. The same method was used to
make 7-12+B−A as 7-12−B−A using enzyme-digested fragments from
7-10+B and 10-12−A. The fragment 7-12−B+A was made from
7-10−B and 10-12+A using BamHI digested pET 11b containing 7-10
fragment as the second generation vector. 
Protein expression and purification 
Escherichia coli strain BL21(DE3) was transformed with pET 11b or
pET 15b plasmid DNA with the various fragments of human FN
cloned into them. FN7-10(−B), 7-10(+B) and 7−B were cloned into
pET15b and all other fragments were cloned into pET 11b. Overnight
bacterial cultures were pelleted and the washed pellet resuspended in
fresh LB medium with ampicillin (50 µg/ml). After a 3 hour period
of growth in 1 liter of LB with ampicillin, IPTG was added at a final
concentration of 2 mM and the cultures were shaken at 37°C for
another 3 hours. The protocol for induction and purification of the
expressed proteins has been described previously (Aukhil et al.,
1993). All the expressed proteins were soluble (seen in the supernatant
after cell lysis and centrifugation). Ammonium sulfate precipitation
was the first step followed by ion exchange chromatography on a
Mono-Q column (Pharmacia). The proteins eluted as single peaks at
various salt concentrations ranging from 0.2-0.4 M NaCl. The peak
fractions were pooled and dialyzed thoroughly against 20 mM Tris-
HCl, pH 7.9. Analysis of the purified protein samples on SDS-PAGE
revealed clean single bands. However, upon long term storage at 4°C
(more than 4 weeks) some proteins showed minor bands suggesting
limited proteolysis. The proteins cloned into pET 15b were purified
by affinity chromatography on HIS-BIND resin columns (Novagen)
that were charged with Ni2+. The bound proteins were eluted using
Imidazole, dialyzed against 20 mM Tris-HCl, pH 7.4, were further
purified on the Mono-Q column and the pure fractions finally dialyzed
against 20 mM Tris-HCl, pH 7.9. Protein concentrations were deter-
mined by measuring the absorbance at 278 nm. The extinction coef-
ficient for each protein was calculated and estimated as described pre-
viously (Aukhil et al., 1993). SDS-PAGE was carried out using 5-20%
acrylamide gradient gels under reducing conditions and stained with
Coomassie Blue.
Protein adsorption assay 
The binding of pFN and the recombinant FN polypeptides was
analyzed using an ELISA assay. Briefly, wells in 96-well flat bottom
plastic plates (Falcon) were coated with various concentrations of
each polypeptide in PBS (in triplicate) and incubated overnight at 4°C.
The solution was removed and the wells were washed 3× in PBS. The
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denatured BSA (2 mg/ml, denatured at 80°C for 10 minutes) for 1
hour. The wells were again washed 3× with PBS containing 0.5%
Tween-20. The rat monoclonal antibody 16G3 was added (10 µg/ml,
100 µl/well) to each well and incubated for 2 hours at room temper-
ature. The wells were then washed thoroughly 3× in PBS/Tween and
then incubated with a peroxidase-conjugated goat anti-rat IgG for 2
hours. Finally, the wells were washed again in PBS/Tween and per-
oxidase activity was measured using o-phenylenediamine as a
substrate. The reaction was stopped with 3 M H2SO4. The mount of
polypeptides adsorbed to the well was expressed as the absorbance at
492 nm. Control wells where only heat-denatured BSA was added
were used to determine background levels. 
Cell culture
Nil.8M hamster fibroblasts were obtained from Dr Richard Hynes,
MIT. Cells were cultured in DMEM-H (Dulbecco’s modified Eagle’s
medium with high glucose) with 10% fetal bovine serum and anti-
biotics (penicillin, streptomycin and gentamycin). The evening before
the cell adhesion assays, cells were detached with 0.05% trypsin, 0.53
mM EDTA and replated at about 50% confluence. The next day the
cells were detached again and the effects of trypsin stopped by adding
0.5 mg/ml soy bean trypsin inhibitor. The cells were washed twice in
PBS and then resuspended in DMEM-H (with no serum) and kept on
ice until use.
Gravity cell attachment assay 
The assay was carried out as described by Aukhil et al. (1993) and
Joshi et al. (1993). Wells of 96-well flat bottom polyvinylchloride
plastic microtiter plates (Falcon 3912) were coated with 100 µl of
various concentrations of the recombinant proteins in PBS overnight
at 4°C. The wells were then washed in PBS and the unbound sites in
the wells were blocked by adding 1 mg/ml heat denatured bovine
serum albumin (BSA, denatured by heating to 80°C for 10 minutes,
then cooled to room temperature) for 1 hour at room temperature.
After washing the wells three times in PBS, each well was loaded with
100 µl DMEM containing 5-10×104 cells suspended in the medium.
The plates were incubated for 60 minutes at 37°C in an atmosphere
of 5% CO2. Following the incubation period, the wells were washed
3× with PBS to remove the unbound cells. The bound cells were fixed
and stained with 3.7% formaldehyde and 1% Toluidine Blue or 0.1%
Crystal Violet in PBS for a minimum of 2 hours to overnight at 4°C.
After washing to remove the unbound dye, the bound cells were lysed
with 2% SDS in PBS. The intensity of the color was measured at 595
nm. A blank value corresponding to BSA-coated wells was subtracted
from each value. Data from triplicate wells were averaged for each
time point/protein concentration tested. The standard deviation of the
three wells was typically within 10% of the mean. The assay was
repeated at least three times to establish reproducibility. 
To study the spreading and morphology of cells, 10 µl samples of
the proteins at a concentration of 50 nM were spread on marked
circular spots (6 mm in diameter) in 60 mm tissue culture dishes
(Corning). After overnight incubation at 4°C, the unbound proteins
were removed by aspirating the remaining solution from marked
areas. The dishes were washed in PBS 3×, unbound sites blocked with
BSA, and the cells plated. After 60 minutes of incubation at 37°C, the
dishes were washed and the bound cells fixed/stained as before. The
adherent cells were examined using an inverted microscope and pho-
tographed.
The presence of focal adhesions and actin stress fibers in cells
plated on the recombinant FN fragments were analyzed using
immunofluorescence methods as described by Schneider and Burridge
(1994). Briefly, the recombinant FN fragments or native plasma FN
were coated on individual glass coverslips and allowed to bind for 16
hours. The coverslips were washed in PBS twice and the unbound
sites blocked with heat denatured BSA for 60 minutes. NIL cells were
trypsinized, washed, plated on these coverslips (approx. 2,000 cells),and then placed into 24-well plates. After a 60 minute incubation at
37°C, the medium was removed and the wells with the glass cover-
slips were washed gently three times in PBS. The bound cells were
fixed in 3.7% formaldehyde for 10 minutes, then washed in Tris-
buffered saline (TBS: 50 mM Tris-HCl, 150 mM NaCl, 0.1% NaN3,
pH 7.6) for 5 minutes. The coverslips, with the cells attached to them,
were incubated sequentially in 0.5% Triton for 7 minutes, TBS for 5
minutes, primary antibody to vinculin (mAB 7F9) for 60 minutes at
37°C, TBS for 5 minutes, secondary antibody (DAM-R, Chemicon,
1:25 in TBS), TBS for 5 minutes, dipped into water and then mounted
on Mowiol (Calbiochem. Corp.). The coverslips were examined under
a Zeiss fluorescence microscope and the images captured on T-MAX
film (Kodak). To identify actin, coverslips were stained with phal-
loidin (Molecular Probes) at 1:500 dilution.
Centrifugal cell adhesion assay 
96-well U-bottom polyvinylchloride plastic microtitre plates (Falcon
3911) were coated with 100 µl/well of the different concentrations of
the recombinant proteins in PBS by overnight adsorption at 4°C. The
wells were washed and unbound sites blocked with 10 mg/ml of BSA
in PBS. 100 µl of a cell suspension containing 5-10×103 cells were
placed in each well and the cells allowed to settle/adhere for 15
minutes at 37°C in an atmosphere of 5% CO2. Following this incu-
bation period, the plate was centrifuged at 250 g for 5 minutes at 4°C
in a Sorval RT6000B centrifuge. The medium in the wells was gently
removed and replaced with 17.5% formaldehyde with 0.005% Crystal
Violet in PBS for fixation for at least one hour. The fixative was then
removed and the wells washed gently in PBS. The effects of cen-
trifugation on the adhesion of cells to the coated ligands was deter-
mined by examining the cells in the round bottom wells and scoring
as follows. Wells that showed complete pelleting of the cells were
scored as 0 (e.g. BSA coated wells), wells that displayed maximum
resistance to centrifugation and showed adherent cells received a score
of 3 (e.g. plasma fibronectin), wells with cells showing more adherent
cells than pelleted cells received a score of 2, and finally cells that
showed more pelleted cells than adherent cells received a score of 1.
In addition, the center of each well was photographed.
RESULTS
Biochemical characterization of the bacterial
expression proteins
A total of ten different expression proteins corresponding to
the various type-III domains of human FN were made and their
nomenclature is shown in Fig. 1. The oligonucleotide primers
used to amplify the domain specific recombinant fragments of
human FN are shown in Table 1. All the cDNA fragments were
sequenced to verify the fidelity of DNA amplification by Taq
polymerase. When cloned into the prokaryotic expression
vector pET11b and induced by IPTG, all of them expressed the
protein well with the yield varying between constructs. All the
recombinant proteins were soluble and could be easily purified
by a combination of ammonium sulfate precipitation followed
by ion exchange chromatography on Mono-Q columns. When
necessary, an additional step of gel filtration was carried out on
Superdex-75 column. The purified expression proteins were
analyzed by SDS-PAGE, and demonstrated high levels of
purity (Fig. 2). Storage at 4°C (>4 weeks) in some instances
led to a partial degradation, as evidenced by doublet bands that
stained with the monoclonal antibody to domain #10 on
western blots (data not shown). Hence experiments were
carried out using fresh batches (within 2-3 weeks afer purifi-
cation) of recombinant FN fragments. The molecular masses
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Fig. 1. Diagrammatic illustration of the recombinant human FN fragment constructs. The primers for amplification of the cDNA were designed
to begin and end precisely at the various domain boundaries.
Fig. 2. SDS-PAGE of purified recombinant human FN fragments.
Samples were run on a 5-20% acrylamide gel and stained with
Coomasie blue. Lane 1 is molecular mass markers (kDa), lane 2 is
plasma FN and the purified recombinant human FN fragments, all
purified from the pET expression vector are shown as marked above
the lanes. and extinction coefficients for each of these recombinant
fragments are shown in Table 2. Fragments made in pET 15b
with the histidine tag showed no difference in cell adhesion
assays compared to similar fragments made in pET 11b
without the histidine tag. 
Adsorption of recombinant FN fragments to plastic
surface 
A modified ELISA was used to determine the binding of FN
fragments to wells of plastic plates used for cell adhesion
assays. Using the monoclonal antibody 16G3 to the 10th type-
III repeat of FN (Nagai et al., 1994), the four large fragments
(FN #7-12 with and without IIIB and IIIA) and the four smaller
fragments (FN #7-10+/−IIIB; FN #10-12+/−IIIA) were tested
for adhesion to plastic at concentrations ranging from 1 to 100
nM. The data are shown in Fig. 3 and all eight recombinant
fragments showed adsorption to plastic wells. Since the mono-
clonal antibody was used at only one concentration, it was
found to be insufficient giving a premature saturation reading
for the binding of protein fragments. The apparent saturation of
the protein fragments at 50 nM concentration was later found
to be inaccurate since cell adhesion assays showed increasing
adhesion for some fragments up to 100 nM concentration. 
Cell adhesion by gravity assays and effects on cell
spreading
The results from gravity cell attachment assays are shown in
Fig. 4. Human plasma FN was used as positive control, and as
expected, showed good adhesion at 50 nM concentration. The
construct FN #7-10+B also showed adhesion at 50 nM that was
comparable to plasma FN. The absence of spliced domain IIIB
from the FN #7-10 construct reduced the adhesion by approxi-
mately 50%, and even at concentrations of 200 nM had not
reached that seen for FN #7-10+B at 50 nM (as per assays in
multiwell plates). The constructs FN #10-12 with and without
IIIA showed significantly less adhesion of cells even at con-
centrations as high as 200 nM. In general, the presence of
adjacent domains at the N-terminal end of the 10th type-III
domain with the RGD sequence appeared to favor cell adhesion
and this was enhanced when domain EIIIB was included. The
signifance of domains at the N-terminal end of the tenth domain(FN III #7,8,9) in enhancing adhesion was further confirmed by
testing cell adhesion to larger fragments that contained type-III
domains both at the N-terminal (FNIII # 7-9) and C-terminal
ends (FNIII #11,12) of the tenth type-III domain. For example,
as shown in Fig. 4, the order of cell adhesion to these fragments
was (#7-12+B−A) > (#7-12+B+A) > (#7-12−B−A) >(#7-12−
B+A). In both the smaller as well as the larger fragments, the
inclusion of domain IIIA appeared to reduce the adhesion of
cells while the inclusion of IIIB appeared to enhance it. 
Immunofluorescence staining for focal adhesions
and cytoskeleton 
NIL cells plated on glass coverslips coated with the various
recombinant FN fragments were stained with mAB to vinculin
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Table 1.  Oligonucleotide primers used to clone the fragments of human FN
Primer Sequence and translation
Type III domain 7 Fwd. ACAGGATCCATATGCCATTGTCTCCACCAACAAAC
======= 
M     P      L     S      P     P      T     N
Type III domain10 Fwd. GCCGGATCCATATGGTTTCTGATGTTCCGAGG
========
M     V     S     D     V     P      R
Type III domain 10 Rev TCCATTAATTACCGAACATAGGATCCCAA
=======
S      I     N     Y      R     T     *
Type III domain 12 Rev TTGTCACCACTCTGGAGTAAGGATCCCCAC 
=======
V     T      T     L      E      *
ED-B domain Fwd. GATAGAATTCATATGGAGGTGCCCCAGCTCACT
-----------
M    E      V      P     Q     L     T
ED-B domain Rev. ACACTGACACAGCAAACGTAAGAATTCCCT
------------
T     L     T      Q     Q      T     *
ED-A domain Fwd. CAGAGGATCCATATGAACATTGATCGCCCTAAA
=======
M     N      I      D     R     P     K
ED-A domain Rev. ATTGGAACCCAGTCCACATAAGGATCCGCA
=======
I      G     T      G     S     T      *
The reverse primer is listed as the sense strand (with translation), but the anti-strand was the sequence actually used. NdeI restriction sites are indicated by
underline; BamHI sites are double underlined; EcoRI sites are indicated by -----. The asterisks show the stop codons.to examine the focal adhesions and with phalloidin to examine
the actin network. Since the gravity adhesion assays had shown
differences between the abilities of the various fragments to
allow adhesion of cells at 50 nM concentrations, the coverslips
were also coated at the same concentration. As shown in Fig.
5.1, the fragment FN#7-10+IIIB showed cell spreading and
strong staining for focal adhesions that was comparable to
native plasma FN (Fig. 5.9). The focal adhesions were also
more prominent in cells plated on FN#7-10+IIIB (Fig. 5.1)
than in cells plated on FN#7-10−IIIB (Fig. 5.2). The fragments
FN#10-12−IIIA (Fig. 5.3) and FN#10-12+IIIA (Fig. 5.4)
showed very few cells adhering and virtually no spreading. No
significant focal adhesions were detectable in cells plated on
these fragments. In the larger FN#7-12 fragments, the differ-
ences in focal adhesions were subtle, although the fragments
FN#7-12+IIIB+IIIA (Fig. 5.5), FN#7-12−IIIB−IIIA (Fig. 5.6)
and FN#7-12+IIIB−IIIA (Fig. 5.7) showed slightly more
spreading of cells and focal adhesions compared to the large
fragment FN#7-12−IIIB+IIIA (Fig. 5.8).Table 2. Biochemical characterization o
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ε=(Y×1,400+W×5,600)molecular mass. Y, Tyr; W, Trp.
OD278/ε = protein concentration (mg/ml).The organization of actin stress fibers was also examined in
these cells by staining with phalloidin. Although the immuno-
fluorescence was not as bright as that seen with staining for
focal adhesions, the findings appeared to parallel those
observed for focal adhesions and in the case of the larger
fragments, the fragment FN7-12−IIIB+IIIA showed a less
intense staining for actin as compared to the other fragments
(Fig. 6).
Centrifugal cell adhesion assay
This assay was designed as an indicator of the relative strengths
of cell adhesion to the various recombinant FN fragments.
Examples of the scoring criteria (0-3) are shown in Fig. 7. Cells
plated on native plasma FN showed resistance to centrifugal
detaching forces fifteen minutes after plating them. Other
proteins that offered resistance to detaching centrifugal forces
at low concentrations (50 nM) were FN#7-10+IIIB and FN#7-
10−IIIB. The FN#10-12 fragments showed almost complete
pelleting at 50 nM concentrations. In comparison, the largerf recombinant fragments of human FN
ε
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Fig. 3. Adsorption of recombinant human FN fragments to plastic
surfaces. Wells in 96-well plates were coated with dilutions (in
triplicate) of the various recombinant fragments overnight at 4°C.
The next day, wells were washed three times with PBS and incubated
with mAB 16G3 to human FN domain #10 for 2 hours at room
temperature. The wells were again washed three times with PBS-
Tween and then incubated with HRP-conjugated secondary antibody
for 2 hours. Finally, the wells were rinsed thoroughly with PBS
before adding the substrate. Absorbance was read at 492 nm and the
results shown are the means of triplicate values.














































Fig. 4. Gravity cell attachment assay for quantification of cell adhesion
to recombinant human FN fragments. Wells in 96-well plates were
coated overnight with the various dilutions of the respective fragments
and the unbound sites blocked with heat-denatured BSA. Cells were
then plated and after 1 hour at 37°C wells were washed gently to
remove unbound cells. Adherent cells were fixed and stained overnight
in 3.7% formaldehyde with 0.1% Crystal Violet or 1% Toluedene
Blue. Wells were again washed gently and the bound dye released by
lysing the cells in 100 ml of 2% SDS. The absorbance was read at 595
nm. The data represent the mean of triplicate wells and the data trends
were reproducible in three such experiments.FN#7-12 fragments showed mostly resistance to centrifugal
detaching forces with the FN#7-12+IIIB−IIIA showing the best
results followed by the FN#7-12+IIIB+IIIA fragment. These
results were reproducible in three separate experiments using
these recombinant fragments.
DISCUSSION
We have used recombinant fragments of type-III repeats of
human fibronectin in the present study to examine the biolog-
ical functions of the alternatively spliced domains EIIIB and
EIIIA. The prokaryotic expression vectors pET15b and
pET11b (with and without histidine tags respectively, for
purification) yield recombinant fragments that possess biolog-
ical activity in the form of promoting cell adhesion. The crystal
structure of one four-domain fragment of human fibronectin
fragment (FNIII 7-10), refined to 2.0 Å, prepared as described
here, has been recently solved (Leahy et al., 1996), suggesting
that the recombinant fragments fold properly. We encounteredno technical difficulties in the production and purification of
the fibronectin fragments with all the fragments being soluble
in the bacterial lysate and easily purified by a combination of
gel filtration, affinity (for hist-tag proteins made in pET 15b)
and ion-exchange chromatography. The cloning of fragments
based on amplification of cDNA to begin and terminate each
protein at the boundaries of the independently folding domains
successfully yields stable fragments of the FN-III domains. We
had successfully used a similar approach to map the cell- and
heparin-binding domains of human tenascin (Aukhil et al.,
1993). In the present study, by using different combinations of
type-III fragments 7-12 of human FN that include or exclude
the spliced repeats EIIIB and EIIIA, we show that including
the EIIIB repeat enhances the adhesion and spreading of cells.
On the other hand including repeat EIIIA alone reduced the
adhesion and spreading of cells, while including it along with
EIIIB made no difference in terms of cell adhesion and
spreading.
Recombinant fragments of human FN were made to include,
in addition to the type-III repeat #10 with the putative RGD cell
2277EIIIB and EIIIA domains of fibronectinbinding loop, adjacent domains on both sides. Previous studies
have shown that the presence of adjacent type-III domains #9
and #8 are needed to restore the ability of the putative RGD-
containing domain #10 to support cell adhesion and spreading
(Kimizuka et al., 1991). This along with the location of domains
EIIIB (between 7 and 8) and EIIIA (between 11 and 12) dictated
the design of our fragments that extended from repeats 7-12.
The finding that inclusion of domain EIIIB alone in fragments
FN 7-10 and 7-12 enhances the adhesion and spreading of cells
is interesting and points to several possibilities. The first possi-
bility is that the EIIIB domain itself has cell-adhesive proper-
ties via a different integrin, or uses the same alpha5 beta1Fig. 5. Distribution of focal adhesions
in cells plated on the various
recombinant human FN fragments.
Glass coverslips were coated with the
proteins at 50 nM concentration and
unbound sites blocked with BSA. Cells
were plated for 1 hour following which
the glass coverslips were rinsed in PBS
and processed for immunofluorescence
staining of focal adhesions using
antibody to vinculin. The coverslips
were coated as follows : 1= 7-10+B;
2= 7-10−B; 3= 10-12+A; 4= 10-12−A;
5= 7-12+B+A; 6= 7-12−A−B; 7= 7-
12+B−A; 8= 7-12−B+A; 9= pFN. integrin. This was not found to be the case because domain
EIIIB alone or fragment 7+EIIIB did not promote cell adhesion
and were not successful in inhibiting adhesion to the 7-10+B
fragment in competitive assays. Domain EIIIB alone showed no
adhesion at concentrations of up to 10 µM. In competitive inhi-
bition experiments (data not shown), trypsinized cells incubated
with 50 µM of purified fragment EIIIB in DMEM for 15
minutes with gentle shaking at 37°C before plating in wells
coated with 50 nM of the fragments (FN, 7-10, 7-10+B) showed
no inhibition of cell adhesion. The second possibility is that
including domain EIIIB would generate a conformational mod-
ification in the domains downstream, perhaps improving the
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Table 3. Data from centrifugal cell attachment assay
FN 7-10+B 7-10−B 10-12+A 10-12−A 7-12+B+A 7-12−B−A 7-12+B−A 7-12−B+A
1 nM 0.5 0 0 0 0 0.5 0 0.5 0
5 nM 1.5 2 0.5 0 0 1 0.5 1 0.5
10 nM 3 2 1 0 0.5 1.5 1 2 0.5
25 nM 3 2.5 2 0.5 0 1.5 0.5 1.5 0.5
50 nM 3 3 3 0.5 1 2 2 2.5 1.5
100 nM 3 3 3 1 1 2.5 3 3 1.5
200 nM 3 3 3 1 1 3 2.5 3 2
400 nM 3 3 3 1.5 1 3 2.5 3 2.5
600 nM 3 N.D .N.D. 1.5 1.5 N.D. N.D. N.D. N.D.
800 nM 3 N.D. N.D. 2 2 N.D. N.D. N.D. N.D.
1,000 nM 3 N.D. N.D. 2 2 N.D. N.D. N.D. N.D.
N.D., not determined.
Fig. 6. Distribution of actin stress fibers
in cells plated on the various
recombinant human FN fragments. Glass
coverslips were coated with the proteins
at 50 nM concentration and unbound
sites blocked with BSA. Cells were
plated for 1 hour following which the
glass coverslips were fixed, subsequently
rinsed and the actin stress fibers stained
with phalloidin. The coverslips were
coated as follows : 1= 7-10+B; 2= 7-10−
B; 3= 10-12+A; 4= 10-12−A; 5= 7-
12+B+A; 6= 7-12−A−B; 7= 7-12+B−A;
8= 7-12−B+A; 9= pFN. 
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Fig. 7. Centrifugal cell adhesion assay. Round-bottom wells in 96-
well plates were coated with recombinant fragments of human FN
overnight. After blocking the unbound sites with heat-denatured BSA,
cells were plated and allowed to adhere for 15 minutes. The entire 96
plate was then centrifuged at 250 g for 5 minutes. The medium was
then gently aspirated and the cells fixed with 3.7%
formaldehyde/0.1% Crystal Violet overnight. The wells were rinsed
again and the center of the round-bottom wells examined and
photographed. (A) Examples of scoring criteria are 0 for complete
pelleting, 1 for mostly pelleting in the center with a few cells resisting
detachment around the periphery, 2 for cells that are mostly resisting
detachment but a few clusters at the center and, 3 for cells that have
resisted detachment with no pelleting or clusters either in the center or
in the periphery. (B) Examples of centrifugal assays on the various
recombinant fragments of human FN. BSA is the negative control
giving 0 scores and pFN is the positive control giving scores of 3.
A
B
access to integrin binding sites in domain 10 and 9. To this
effect, a previous study by Carnemolla et al. (1992) had found
that including the EIIIB repeat in their β-galactose-fibronectin
fusion protein had unmasked cryptic sequences suggesting con-
formational effects of including EIIIB. More recently, the
crystal structure of the recombinant human FN fragment 7-10
(Leahy et al., 1996) suggests some interesting structural conse-
quences. The fragment FN 7-10, made up of four contiguous
type-III modules shows relative rotations ranging from 43 to
160°. In addition, the solvent-accessible surface area buried
between domains is as follows: 587 Å between domains 7 and
8, 527 Å between domains 8 and 9, and only 333 Å between
domains 9 and 10. It is also interesting to note that an almost
twofold rotation axis relates domain 8 and 9. In summary, the
small rotation and tilt angles relating domains 9 and 10 renders
this segment of the 7-10 fragment almost cylindrical and
contrasts with the combined tilts and rotations relating domains
7-9 giving that segment a spiral configuration (Leahy et al.,
1996). While definite information on the structural effects of
including EIIIB would require crystallographic analysis, it is
tempting to speculate on the structural aspects. It is possible that
the large interface between domains 7 and 8 contains sequences
that may have synergistic functions in promoting the adhesion
and spreading of cells. While these interface sequences are
buried and may be masked in the [−EIIIB] isoform, the
inclusion of EIIIB may be exposing these proximal sequences.
The other possibility is that the inclusion of EIIIB may affect
the polarity of the domains downstream resulting in the posi-
tioning of the RGD cell-binding site in domain 10 and the other
recently-discovered synergy sequences (PHSRN) in domain 9
(Aota et al., 1994) to enhance the adhesion and spreading of
cells. Since domain 9 contains more basic amino acids and is
located immediately before domain 10, an extra domain that
may influence the proper folding and conformation of the pos-
itively charged region in domain 9 and the RGDS site could be
enhancing the biological function of the synergy sequences
(Kimizuka et al., 1991). The final possibility is that the NIL
cells may be using another receptor that may be recognizing
other sequences as ligands in addition to the alpha5 beta1
integrin used to bind to the RGD sequence. This is currently
being investigated using blocking antibodies to alpha 5 integrin
in cell adhesion assays. 
Recent studies by Chen and Culp (1996) and Xia and Culp
(1994) have reported some cell adhesion to fragments EIIIB and
EIIIA that were made as independent domains or in conjunction
with their adjacent domains (7-B-8 and 11-A-12). However, the
experimental conditions were very different with observation
periods of 4 hours. The observation period in our experiments on
cell adhesion was 1 hour for adhesion/spreading and only 15
minutes for the centrifugal assay. Our findings on the larger
fragment 7-12+A differ from those reported by Xia and Culp
(1994) where they report adhesion activity in domain EIIIA. The
differences could be explained by the duration of adhesion assay
(4 hours versus 1 hour in our study), concentration of the proteins
used and cell types used. The cells that adhered to fragment 7-
10+B had spread just as well as pFN at equimolar concentrations.
Immunostaining with antibodies to vinculin revealed a pattern of
focal adhesion distribution in the cells plated on 7-10+B fragment
that was comparable if not better to that seen on pFN at 50 nM
concentrations. Similarly, the distribution of the actin cytoskele-
tal network was comparable. However, the 7-10−B fragment
2280 M. Hashimoto-Uoshima and othersshowed slightly fewer focal adhesions and less well-organized
actin network. The fact that the fragments 10-12 with and without
EIIIA showed very little adhesion and virtually no spreading is
not surprising given the previous findings that the RGD-contain-
ing domain alone is not sufficient to promote cell adhesion. Also,
these findings suggest that domains 11 and 12 at the C-terminal
end do not offer any kind of synergistic help to the putative RGD-
containing domain 10. Again, structural studies (Leahy et al.,
1996; Main et al., 1992) imply the need for additional specific
domains on the N-terminal end of the RGD loop, perhaps acting
to stabilize the integrin. One of the interesting findings in the
present study is the improved spreading and distribution of focal
adhesions in cells plated on the larger 7-12 fragments. Here, the
inclusion of EIIIB alone or both EIIIB and EIIIA appears to help
adhesion and spreading of cells, while the inclusion of EIIIA in
the absence of EIIIB keeps the cells from establishing good focal
adhesions. The findings on the distribution of focal adhesions and
actin stress fibers complement those of the centrifugal cell
adhesion assay. This assay was designed to indirectly test the
adhesive strength by examining the balance between centrifugal
forces and cell substrate adhesion.. In non-adherent or weakly
adherent substrata, cells may form a pellet due to the predomi-
nance of centrifugal force. With increasing strengths of cell-
substrate adhesion, cells resist centrifugal forces. Under the
criteria used for scoring, a score of 3 means almost complete
resistance to detachment by centrifugal forces in round-bottom
wells. It should be emphasized that the cells were allowed to
adhere only for 15 minutes. Cells on pFN showed scores of 3 at
concentrations as low as 10 nM and fragments 7-10+B and 7-
10−B were next, showing scores of 3 at about 50 nM concentra-
tions. The larger fragments showed scores of 3 at 100 nM con-
centrations only when EIIIB alone was included or both EIIIB
and EIIIA were excluded. Cells on the fragment 7-12+A did not
show scores of 3 even at the highest concentration tested (600
nM). Similarly cells plated on the smaller fragments 10-12+A
and 10-12−A never reached scores of more than 2 even at 1,000
nM concentrations. Taken together, the data on distribution of
focal adhesions and the centrifugal cell attachment assay suggest
that the inclusion of EIIIB enhances the adhesion and spreading
of cells while including EIIIA alone in the larger fragment nega-
tively affects the adhesion and spreading of cells. It is tempting
to speculate that the inclusion of both domains EIIIB and EIIIA
in the FN molecule may be a biological mechanism of achieving
cell adhesion to a degree that facilitates the process of locomo-
tion where both adhesion and loss of adhesion are needed for the
advancement of cells. The EIIIB+/EIIIA+ isoform of FN is
common during embryonic development and wound healing
(french-Constant and Hynes, 1989), both events where cell
migration is important. More recently, it has been shown that the
spliced domains EIIIB and EIIIA are included in the FN seen
during the morphogenesis of ‘FN dependent’ structures such as
somites, notochord and the vasculature (Peters and Hynes, 1996).
Similarly, the expression of the EIIIA and EIIIB spliced variants
in the adult tissues suggest that these isoforms of FN may be
serving different functions (Peters et al., 1996).
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